Sunday, 30 November 2014

Global Active Pharmaceutical Ingredients Market to 2020 - Worldwide Industry Analysis, Size, Share, Growth, Trends and Forecast

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on

The global Active Pharmaceutical Ingredient market is expected to reach a market size approximately $190 billion by 2020, growing at a CAGR of more than 6.5% from 2014 to 2020. API market is mainly driven by the factors such as patent expiration of major drugs, increased generic medicine sales and high uptake of biologics. High  Potential Active Pharmaceutical Ingredients (HPAPI) are also driving the API market growth globally as these compounds are very effective in treatment of diseases such as cancer, respiratory disorders and hormonal imbalances and HPAPI growth is mainly driven by its therapeutic applications in Oncology.

To Browse a Full Report with Toc:

Active Pharmaceutical Ingredients are the active substances in a drug intended to achieve pharmacological activity which is having direct effect on diagnosis or treatment of disease. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or improved from natural source. The report categorizes the API market based on product type, business type and applications. The market assessment of the above mentioned segments is made across the geographies such as North America, Europe, Asia-Pacific, LATAM and MENA.

Depending on the product type the API market is segmented into synthetic API, Biotech API, and HPAPI. Synthetic API commanded the largest share in 2013 and is growing at a steady pace, whereas the biotech API is expected to register the highest CAGR during the forecast period, strongly driven by the monoclonal antibodies and recombinant proteins. Depending on the applications the API market is categorized into oncology, cardiovascular and hematopoietic system, central nervous system, anti-infective, gastrointestinal, respiratory system, metabolic disorders, genito-urinary disorders, and others. Cardiovascular commanded the largest share of more than 40% in 2013 and is growing at a steady pace, whereas oncology is expected to register the highest CAGR during the forecast period. HPAPI commanded the largest share in the oncology application segment in 2013 and is growing at a highest CAGR in the anti-infectives segment.

By business type the API it is segmented into captive and merchant and by customer base the market is further segmented into branded/innovative and generics.
The global API market report evaluated detailed information about the market trends of diverse segmentation. Further market dynamics, along with challenges, and opportunities are described.

This report provides an in-depth market assessment across the below listed segments:

1. Global API Market, by Synthesis:
Synthetic Chemical API
Biotech API
Mammalian cell culture
Monoclonal antibodies
Recombinant proteins
Insulin analog
Growth hormone manufacturing
Interferon manufacturing
2. Global API Market, by Business type:
3. Global API Market, by Therapeutic Applications:
Cardiovascular and hematopoietic system
Central nervous system
Respiratory system
Gastrointestinal disorders
Hormone-related disorders
Metabolic disorders
Genitourinary disorders
Musculo-skeletal disorders
4. Global API Markets, by Region:
North America
Rest of World

All Reports of this Category Here:

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US: 

For More Information Kindly Contact:
Website @

No comments:

Post a Comment